Semibranch CMD branched aortic stentgraft: bEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design
Study summary
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* 18 years or older
* Presence of pararenal or thoracoabdominal aortic pathology
* Treatment planned a semibranch device branch from Artivion
* Availability of the patients during the follow up period
* Informing patients about the study and providing written informed consent
Exclusion Criteria:
* Women of childbearing age
* Patients under 18 years
Primary outcome measure(s)
Freedom from target vessel instability — 30 days after intervention primary patency and freedom from stenosis fo the semibranch
Mortality — 30 days after intervention overall mortality rate during 30 days after intervention
technical success — During intervention Feasibility in terms of cannulation and stentgrafting of the semibranches
Trial sites (1)
Facility
City
Region
Status
Muenster University Hospital
Münster
Germany
Recruiting
More University Hospital Muenster trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.